tazarotene has been researched along with tretinoin in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.00) | 18.2507 |
| 2000's | 32 (80.00) | 29.6817 |
| 2010's | 5 (12.50) | 24.3611 |
| 2020's | 1 (2.50) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Charton, J; Deprez, B; Deprez-Poulain, R; Hennuyer, N; Staels, B; Tailleux, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Leyden, JJ | 2 |
| Kawashima, M; Maeguchi, M; Muraki, T; Ogawa, A; Uchida, Y; Yoshioka, T | 1 |
| Törmä, H; Vahlquist, A; Virtanen, M | 1 |
| Kakita, L | 1 |
| Grove, GL; Leyden, J | 1 |
| Berson, D; Fivenson, DP; Ling, M; Stein, LF; Tanghetti, EA; Webster, GF | 1 |
| Bershad, S | 1 |
| Bhawan, J; Gibson, JR; Kang, S; Lew-Kaya, DA; Leyden, JJ; Lowe, NJ; Matsumoto, RM; Ortonne, JP; Phillips, TJ; Sefton, J; Walker, PS; Weinstein, GD | 1 |
| Berson, D; Lee, J; Leyden, JJ; Miller, B; Tanghetti, EA; Ung, M | 1 |
| Liao, DC | 1 |
| Baker, MD; Georgeian, K; Gilbert, R; Greenspan, A; Loesche, C; Poncet, M; Soto, P; Vendetti, N | 1 |
| Gifford, M; Goldman, M; Kang, S; Lowe, N; Poulin, Y; Rosenzweig, H; Tanghetti, E; Tse, Y; Yamauchi, P | 1 |
| Stern, RS | 1 |
| Del Rosso, JQ | 1 |
| Noble, S; Scott, LJ; Waugh, J | 1 |
| Brooke, R; Griffiths, C; Samuel, M | 3 |
| Brooke, RC; Griffiths, CE; Hollis, S; Samuel, M | 1 |
| Lei, XB; Qiu, S; Ran, LW; Tan, SS; Wang, WJ; Zeng, WH | 1 |
| Ran, L; Tan, S; Tan, W; Wang, W; Zeng, W; Zhang, R | 1 |
| Hamerlynck, JV; Middeldorp, S; Scholten, RJ | 1 |
| Scheinfeld, N | 1 |
| Chern, WH; Hofland, HE; Houlden, RJ; Hsia, E; Johnston, MJ | 1 |
| Bikowski, J; Callender, VD; Del Rosso, JQ; Draelos, ZD; Tanghetti, E | 1 |
| Date, A; Korting, HC; Mukherjee, S; Patravale, V; Roeder, A; Weindl, G | 1 |
| Dhawan, S; Kircik, L; Tanghetti, E; Torok, H | 1 |
| Griffiths, CE; Ogden, S; Samuel, M | 1 |
| Gollnick, H; Thielitz, A | 1 |
| Liu, P; Tan, SS; Wang, QY; Wang, YX | 1 |
| Kircik, LH | 1 |
| Darlenski, R; Fluhr, JW; Surber, C | 1 |
| Brooke, R; Griffiths, CE; Hollis, S; Samuel, M | 1 |
| Bonati, LM; Silverberg, NB; Yeh, L | 1 |
| Chen, J; Fang, Z; Gao, L; Li, B; Li, Y; Shen, F; Wang, L; Wang, Y; Wu, M; Ye, J; Yuan, Z | 1 |
| Abdelmaksoud, A; Galadari, H; Goldust, M; Grabbe, S; Gupta, M; Karagaiah, P; Kassir, M; Katsambas, A; Lotti, T; Sonthalia, S; Wollina, U | 1 |
19 review(s) available for tazarotene and tretinoin
| Article | Year |
|---|---|
Topical treatment of acne vulgaris: retinoids and cutaneous irritation.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Gels; Humans; Keratolytic Agents; Naphthalenes; Nicotinic Acids; Ointments; Retinoids; Tretinoin | 1998 |
Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Dermatologic Agents; Double-Blind Method; Gels; Keratolytic Agents; Multicenter Studies as Topic; Naphthalenes; Nicotinic Acids; Randomized Controlled Trials as Topic; Treatment Outcome; Tretinoin | 2000 |
Developments in topical retinoid therapy for acne.
Topics: Acne Vulgaris; Adapalene; Dermatologic Agents; Drug Combinations; Humans; Keratolytic Agents; Naphthalenes; Nicotinic Acids; Receptors, Retinoic Acid; Tretinoin; Vitamin A | 2001 |
Management of acne.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Algorithms; Anti-Bacterial Agents; Benzoyl Peroxide; Contraceptives, Oral; Controlled Clinical Trials as Topic; Cost-Benefit Analysis; Decision Trees; Dermatologic Agents; Dicarboxylic Acids; Humans; Isotretinoin; Macrolides; Naphthalenes; Nicotinic Acids; Salicylates; Tretinoin; United States | 2003 |
Topical retinoids in the management of acne: the best path to clear results.
Topics: Acne Vulgaris; Adapalene; Dermatologic Agents; Humans; Keratolytic Agents; Meta-Analysis as Topic; Multicenter Studies as Topic; Naphthalenes; Nicotinic Acids; Randomized Controlled Trials as Topic; Retinoids; Treatment Outcome; Tretinoin; United States | 2004 |
Meta-analysis of topical tazarotene in the treatment of mild to moderate acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adult; Dermatologic Agents; Drug Administration Schedule; Female; Gels; Humans; Male; Multicenter Studies as Topic; Naphthalenes; Nicotinic Acids; Randomized Controlled Trials as Topic; Retinoids; Severity of Illness Index; Time Factors; Treatment Outcome; Tretinoin; United States | 2004 |
Spotlight on adapalene in acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Dermatologic Agents; Drug Administration Schedule; Gels; Humans; Multicenter Studies as Topic; Naphthalenes; Nicotinic Acids; Randomized Controlled Trials as Topic; Treatment Outcome; Tretinoin | 2004 |
Wrinkles.
Topics: Antioxidants; Dermabrasion; Dermatologic Agents; Humans; Isotretinoin; Laser Therapy; Nicotinic Acids; Skin Aging; Sunscreening Agents; Tretinoin | 2003 |
Interventions for photodamaged skin.
Topics: Administration, Cutaneous; Dermatologic Agents; Humans; Isotretinoin; Keratosis; Laser Therapy; Nicotinic Acids; Randomized Controlled Trials as Topic; Skin Aging; Skin Diseases; Sunlight; Tretinoin | 2005 |
Wrinkles.
Topics: Ascorbic Acid; Dermabrasion; Humans; Isotretinoin; Laser Therapy; Nicotinic Acids; Skin Aging; Sunscreening Agents; Tretinoin; Vitamin E | 2004 |
[From the Cochrane Library: Improvement of photodamaged skin with retinoid creams and not with other local treatments].
Topics: Administration, Cutaneous; Dermatologic Agents; Dose-Response Relationship, Drug; Humans; Nicotinic Acids; Randomized Controlled Trials as Topic; Skin Aging; Skin Diseases; Sunlight; Tretinoin | 2006 |
Wrinkles.
Topics: Dermabrasion; Humans; Isotretinoin; Laser Therapy; Nicotinic Acids; Skin Aging; Sunscreening Agents; Tretinoin | 2005 |
Schools of pharmacology: retinoid update.
Topics: Adapalene; Humans; Isotretinoin; Keratolytic Agents; Naphthalenes; Nicotinic Acids; Retinoids; Skin Diseases; Tretinoin | 2006 |
Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety.
Topics: Adapalene; Dermatologic Agents; Dermis; Epidermis; Humans; Naphthalenes; Nicotinic Acids; Retinaldehyde; Retinoids; Skin Aging; Treatment Outcome; Tretinoin; Vitamin A Deficiency | 2006 |
A review of tazarotene in the treatment of photodamaged skin.
Topics: Drug Therapy, Combination; Humans; Keratolytic Agents; Nicotinic Acids; Retinoids; Skin Aging; Treatment Outcome; Tretinoin | 2008 |
Topical retinoids in acne vulgaris: update on efficacy and safety.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Humans; Isotretinoin; Naphthalenes; Nicotinic Acids; Retinoids; Safety; Tretinoin | 2008 |
Topical retinoids in the management of photodamaged skin: from theory to evidence-based practical approach.
Topics: Administration, Topical; Dermatologic Agents; Evidence-Based Medicine; Humans; Isotretinoin; Nicotinic Acids; Retinoids; Skin Aging; Tretinoin; Ultraviolet Rays; Vitamin A | 2010 |
WITHDRAWN: Interventions for photodamaged skin.
Topics: Administration, Cutaneous; Dermatologic Agents; Humans; Isotretinoin; Keratosis; Laser Therapy; Nicotinic Acids; Randomized Controlled Trials as Topic; Skin Aging; Skin Diseases; Sunlight; Tretinoin | 2015 |
Selective RAR agonists for acne vulgaris: A narrative review.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Dermatologic Agents; Humans; Nicotinic Acids; Randomized Controlled Trials as Topic; Receptors, Retinoic Acid; Retinoids; Treatment Outcome; Tretinoin | 2020 |
8 trial(s) available for tazarotene and tretinoin
| Article | Year |
|---|---|
Randomized facial tolerability studies comparing gel formulations of retinoids used to treat acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Child; Double-Blind Method; Gels; Humans; Keratolytic Agents; Nicotinic Acids; Retinoids; Tretinoin | 2001 |
Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial.
Topics: Acne Vulgaris; Adolescent; Adult; Child; Double-Blind Method; Female; Gels; Humans; Keratolytic Agents; Male; Nicotinic Acids; Retinoids; Treatment Outcome; Tretinoin | 2001 |
Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily f
Topics: Administration, Cutaneous; Adult; Dermatologic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Face; Female; Humans; Hyperpigmentation; Male; Nicotinic Acids; Prospective Studies; Retinoids; Skin Aging; Treatment Outcome; Tretinoin; United States | 2001 |
Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Child; Cost-Benefit Analysis; Dermatologic Agents; Double-Blind Method; Drug Administration Schedule; Facial Dermatoses; Female; Gels; Humans; Male; Nicotinic Acids; Severity of Illness Index; Treatment Outcome; Tretinoin; United States | 2002 |
Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations.
Topics: Adapalene; Adult; Aged; Dermatologic Agents; Double-Blind Method; Drug Interactions; Erythema; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Nicotinic Acids; Probability; Sensitivity and Specificity; Skin Irritancy Tests; Tretinoin | 2003 |
Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study.
Topics: Administration, Topical; Dermatologic Agents; Double-Blind Method; Emollients; Face; Female; Humans; Hyperpigmentation; Male; Middle Aged; Nicotinic Acids; Skin Aging; Treatment Outcome; Tretinoin | 2004 |
Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Child; Clindamycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gels; Humans; Keratolytic Agents; Male; Middle Aged; Nicotinic Acids; Ointments; Retinoids; Severity of Illness Index; Treatment Outcome; Tretinoin | 2007 |
Tretinoin microsphere gel pump 0.04% versus tazarotene cream 0.05% in the treatment of mild-to-moderate facial acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Child; Female; Gels; Humans; Keratolytic Agents; Male; Microspheres; Nicotinic Acids; Pilot Projects; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Tretinoin; Young Adult | 2009 |
13 other study(ies) available for tazarotene and tretinoin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivatives.
Topics: Carboxylic Acids; Oxadiazoles; Receptors, Retinoic Acid; Retinoids | 2009 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of tazarotene, an acetylenic retinoid, on human dermal fibroblast.
Topics: Bromodeoxyuridine; Cell Division; Cells, Cultured; Collagen; Dermatologic Agents; DNA; Fibroblasts; Fibrosis; Humans; Nicotinic Acids; Receptors, Retinoic Acid; Retinoids; Skin; Tretinoin | 1998 |
Keratin 4 upregulation by retinoic acid in vivo: a sensitive marker for retinoid bioactivity in human epidermis.
Topics: Administration, Topical; Adult; Biomarkers; Dose-Response Relationship, Drug; Female; Gene Expression; Humans; Immunohistochemistry; Keratins; Male; Middle Aged; Nicotinic Acids; Receptors, Retinoic Acid; Retinoids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin; Time Factors; Tretinoin; Up-Regulation | 2000 |
Questions & answers. Of all the treatments that promise to improve the appearance of aging skin, which ones have been medically proven to actually work?
Topics: Cryotherapy; Dermatologic Agents; Humans; Keratolytic Agents; Laser Therapy; Nicotinic Acids; Skin Aging; Tretinoin | 2004 |
[Effects of all-trans-retinoic acid, acitretin and tazarotene on apoptosis and Bax/Bcl-2 expressions of human melanoma cells A375 and the significance].
Topics: Acitretin; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Humans; Melanoma; Nicotinic Acids; Proto-Oncogene Proteins c-bcl-2; Skin Neoplasms; Tretinoin; Tumor Cells, Cultured | 2005 |
Effects of ATRA, acitretin and tazarotene on growth and apoptosis of Tca8113 cells.
Topics: Acitretin; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Humans; Nicotinic Acids; Tongue Neoplasms; Tretinoin | 2005 |
Effects of topically applied acitretin in reconstructed human epidermis and the rhino mouse.
Topics: Acitretin; Administration, Topical; Animals; Disease Models, Animal; Epidermis; Female; Filaggrin Proteins; Humans; Interleukin-1alpha; Interleukin-8; Keratin-10; Keratin-19; Keratolytic Agents; Male; Mice; Mice, Hairless; Nicotinic Acids; Psoriasis; Tretinoin | 2008 |
Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Minocycline; Naphthalenes; Nicotinic Acids; Retinoids; Treatment Outcome; Tretinoin | 2006 |
[Effects of all-trans retinioic acid and tazarotene on MMP-1 and TIMP-1 expression in cultured human fibroblasts after heat shock].
Topics: Cells, Cultured; Fibroblasts; Heat-Shock Response; Humans; Matrix Metalloproteinase 1; Nicotinic Acids; Skin Aging; Tissue Inhibitor of Metalloproteinase-1; Tretinoin | 2009 |
Topical retinoids for acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Dermatologic Agents; Humans; Nicotinic Acids; Retinoids; Treatment Outcome; Tretinoin | 2016 |
Identification of Retinoic Acid Receptor Agonists as Potent Hepatitis B Virus Inhibitors via a Drug Repurposing Screen.
Topics: Acitretin; Adapalene; Antiviral Agents; Cell Line; Cell Survival; Dermatologic Agents; Drug Repositioning; Drug Synergism; Gene Expression; Guanine; Hep G2 Cells; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatocytes; High-Throughput Screening Assays; Host-Pathogen Interactions; Humans; Keratolytic Agents; Nicotinic Acids; Receptors, Retinoic Acid; Transcription, Genetic; Tretinoin; Virus Replication | 2018 |